MedImmune Inc. has licensed its reverse genetics technology to the Research Foundation for Microbial Diseases of Osaka University in Japan (BIKEN) for use in influenza vaccine development and production.

Lees meer..

Cephalon will pay $425 million to settle charges that it promoted three of its drugs for uses that were not approved by the Food and Drug Administration. (CEPH)

Lees meer..

MedImmune Inc. has licensed its reverse genetics technology to the Research Foundation for Microbial Diseases of Osaka University in Japan (BIKEN) for use in influenza vaccine development and production.

Lees meer..

Cardinal Health Inc. is spinning of its tech-focused clinical and medical products businesses into a separate public company, the Dublin corporation said Monday. (CAH) (PG)

Lees meer..

Avant Immunotherapeutics Inc. will change its name to Celldex Therapeutics Inc. on Wednesday.

Lees meer..

PharmAthene Inc., a biodefense research company, has won a federal contract potentially worth $83.9 million to combat anthrax.

Lees meer..

CPC of America Inc. has retained FTI Capital Advisors LLC to explore strategic alternatives for the company.

Lees meer..

German drug maker Merz Pharmaceuticals has appointed a new CEO to lead U.S. operations from its headquarters in Piedmont Centre.

Lees meer..

Poised like a baseball slugger with a favorable count, biotech giant Amgen Inc. is hoping to produce a potential home-run drug at its Boulder labs. (AMGN)

Lees meer..

A privately held, and at one time well-funded, Montgomery County biotechnology company has imploded amid charges and countercharges.

Lees meer..